A {szligbeta}-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy von Harding, Fiona A, Liu, Amy D, Stickler, Marcia, Razo, OJennifer, Chin, Regina, Faravashi, Nargol, Viola, Wendy, Graycar, Tom, Yeung, VPete, Aehle, Wolfgang, Meijer, Daan, Wong, Stephanie, Rashid, MHarunur, Valdes, Ana M, Schellenberger, Volker

Volltext